EMEA (Europe, Middle East and Africa) Eculizumab Market Report 2018

January 2018 | 108 pages | ID: E501E19B53DEN
QYResearch

Abstracts

In this report, the EMEA Eculizumab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Vial), revenue (Million USD), market share and growth rate of Eculizumab for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Eculizumab market competition by top manufacturers/players, with Eculizumab sales volume (K Vial), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Alexion

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Plasma Exchange
• Plasma Infusion

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• PNH
• aHUS
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Eculizumab Market Report 2017

1 ECULIZUMAB OVERVIEW

1.1 Product Overview and Scope of Eculizumab
1.2 Classification of Eculizumab
  1.2.1 EMEA Eculizumab Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Eculizumab Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Plasma Exchange
  1.2.4 Plasma Infusion
1.3 EMEA Eculizumab Market by Application/End Users
  1.3.1 EMEA Eculizumab Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 PNH
  1.3.3 aHUS
  1.3.4 Other
1.4 EMEA Eculizumab Market by Region
  1.4.1 EMEA Eculizumab Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Eculizumab (2012-2022)
  1.5.1 EMEA Eculizumab Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Eculizumab Revenue and Growth Rate (2012-2022)

2 EMEA ECULIZUMAB COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Eculizumab Market Competition by Players/Manufacturers
  2.1.1 EMEA Eculizumab Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Eculizumab Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Eculizumab Sale Price by Players (2012-2017)
2.2 EMEA Eculizumab (Volume and Value) by Type/Product Category
  2.2.1 EMEA Eculizumab Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Eculizumab Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Eculizumab Sale Price by Type (2012-2017)
2.3 EMEA Eculizumab (Volume) by Application
2.4 EMEA Eculizumab (Volume and Value) by Region
  2.4.1 EMEA Eculizumab Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Eculizumab Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Eculizumab Sales Price by Region (2012-2017)

3 EUROPE ECULIZUMAB (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Eculizumab Sales and Value (2012-2017)
  3.1.1 Europe Eculizumab Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Eculizumab Revenue and Growth Rate (2012-2017)
3.2 Europe Eculizumab Sales and Market Share by Type
3.3 Europe Eculizumab Sales and Market Share by Application
3.4 Europe Eculizumab Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Eculizumab Sales Volume by Countries (2012-2017)
  3.4.2 Europe Eculizumab Revenue by Countries (2012-2017)
  3.4.3 Germany Eculizumab Sales and Growth Rate (2012-2017)
  3.4.4 France Eculizumab Sales and Growth Rate (2012-2017)
  3.4.5 UK Eculizumab Sales and Growth Rate (2012-2017)
  3.4.6 Russia Eculizumab Sales and Growth Rate (2012-2017)
  3.4.7 Italy Eculizumab Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Eculizumab Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ECULIZUMAB (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Eculizumab Sales and Value (2012-2017)
  4.1.1 Middle East Eculizumab Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Eculizumab Revenue and Growth Rate (2012-2017)
4.2 Middle East Eculizumab Sales and Market Share by Type
4.3 Middle East Eculizumab Sales and Market Share by Application
4.4 Middle East Eculizumab Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Eculizumab Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Eculizumab Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Eculizumab Sales and Growth Rate (2012-2017)
  4.4.4 Israel Eculizumab Sales and Growth Rate (2012-2017)
  4.4.5 UAE Eculizumab Sales and Growth Rate (2012-2017)
  4.4.6 Iran Eculizumab Sales and Growth Rate (2012-2017)

5 AFRICA ECULIZUMAB (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Eculizumab Sales and Value (2012-2017)
  5.1.1 Africa Eculizumab Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Eculizumab Revenue and Growth Rate (2012-2017)
5.2 Africa Eculizumab Sales and Market Share by Type
5.3 Africa Eculizumab Sales and Market Share by Application
5.4 Africa Eculizumab Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Eculizumab Sales Volume by Countries (2012-2017)
  5.4.2 Africa Eculizumab Revenue by Countries (2012-2017)
  5.4.3 South Africa Eculizumab Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Eculizumab Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Eculizumab Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Eculizumab Sales and Growth Rate (2012-2017)

6 EMEA ECULIZUMAB MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Alexion
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Eculizumab Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alexion Eculizumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 ECULIZUMAB MANUFACTURING COST ANALYSIS

7.1 Eculizumab Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Eculizumab

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Eculizumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Eculizumab Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ECULIZUMAB MARKET FORECAST (2017-2022)

11.1 EMEA Eculizumab Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Eculizumab Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Eculizumab Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Eculizumab Price and Trend Forecast (2017-2022)
11.2 EMEA Eculizumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Eculizumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Eculizumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Eculizumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Eculizumab Sales Forecast by Type (2017-2022)
11.7 EMEA Eculizumab Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Eculizumab
Figure EMEA Eculizumab Sales Volume (K Vial) by Type (2012-2022)
Figure EMEA Eculizumab Sales Volume Market Share by Type (Product Category) in 2016
Figure Plasma Exchange Product Picture
Figure Plasma Infusion Product Picture
Figure EMEA Eculizumab Sales Volume (K Vial) by Application (2012-2022)
Figure EMEA Sales Market Share of Eculizumab by Application in 2016
Figure PNH Examples
Table Key Downstream Customer in PNH
Figure aHUS Examples
Table Key Downstream Customer in aHUS
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Eculizumab Market Size (Million USD) by Region (2012-2022)
Figure Europe Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Eculizumab Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Eculizumab Revenue (Million USD) Status and Forecast by Countries
Figure Africa Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Eculizumab Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Eculizumab Sales Volume and Growth Rate (2012-2022)
Figure EMEA Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Eculizumab Market Major Players Product Sales Volume (K Vial) (2012-2017)
Table EMEA Eculizumab Sales Volume (K Vial) of Major Players (2012-2017)
Table EMEA Eculizumab Sales Share by Players (2012-2017)
Figure 2016 Eculizumab Sales Share by Players
Figure 2017 Eculizumab Sales Share by Players
Figure EMEA Eculizumab Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Eculizumab Revenue (Million USD) by Players (2012-2017)
Table EMEA Eculizumab Revenue Share by Players (2012-2017)
Table 2016 EMEA Eculizumab Revenue Share by Players
Table 2017 EMEA Eculizumab Revenue Share by Players
Table EMEA Eculizumab Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Eculizumab Sales (K Vial) and Market Share by Type (2012-2017)
Table EMEA Eculizumab Sales Share by Type (2012-2017)
Figure Sales Market Share of Eculizumab by Type (2012-2017)
Figure EMEA Eculizumab Sales Market Share by Type (2012-2017)
Table EMEA Eculizumab Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Eculizumab Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Eculizumab by Type in 2016
Table EMEA Eculizumab Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Eculizumab Sales (K Vial) and Market Share by Application (2012-2017)
Table EMEA Eculizumab Sales Share by Application (2012-2017)
Figure Sales Market Share of Eculizumab by Application (2012-2017)
Figure EMEA Eculizumab Sales Market Share by Application in 2016
Table EMEA Eculizumab Sales (K Vial) and Market Share by Region (2012-2017)
Table EMEA Eculizumab Sales Share by Region (2012-2017)
Figure Sales Market Share of Eculizumab by Region (2012-2017)
Figure EMEA Eculizumab Sales Market Share in 2016
Table EMEA Eculizumab Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Eculizumab Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Eculizumab by Region (2012-2017)
Figure EMEA Eculizumab Revenue Market Share Regions in 2016
Table EMEA Eculizumab Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Europe Eculizumab Revenue and Growth Rate (2012-2017)
Table Europe Eculizumab Sales (K Vial) by Type (2012-2017)
Table Europe Eculizumab Market Share by Type (2012-2017)
Figure Europe Eculizumab Market Share by Type in 2016
Table Europe Eculizumab Sales (K Vial) by Application (2012-2017)
Table Europe Eculizumab Market Share by Application (2012-2017)
Figure Europe Eculizumab Market Share by Application in 2016
Table Europe Eculizumab Sales (K Vial) by Countries (2012-2017)
Table Europe Eculizumab Sales Market Share by Countries (2012-2017)
Figure Europe Eculizumab Sales Market Share by Countries (2012-2017)
Figure Europe Eculizumab Sales Market Share by Countries in 2016
Table Europe Eculizumab Revenue (Million USD) by Countries (2012-2017)
Table Europe Eculizumab Revenue Market Share by Countries (2012-2017)
Figure Europe Eculizumab Revenue Market Share by Countries (2012-2017)
Figure Europe Eculizumab Revenue Market Share by Countries in 2016
Figure Germany Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure France Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure UK Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Russia Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Italy Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Benelux Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Middle East Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Middle East Eculizumab Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Eculizumab Sales (K Vial) by Type (2012-2017)
Table Middle East Eculizumab Market Share by Type (2012-2017)
Figure Middle East Eculizumab Market Share by Type (2012-2017)
Table Middle East Eculizumab Sales (K Vial) by Applications (2012-2017)
Table Middle East Eculizumab Market Share by Applications (2012-2017)
Figure Middle East Eculizumab Sales Market Share by Application in 2016
Table Middle East Eculizumab Sales Volume (K Vial) by Countries (2012-2017)
Table Middle East Eculizumab Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Eculizumab Sales Volume Market Share by Countries in 2016
Table Middle East Eculizumab Revenue (Million USD) by Countries (2012-2017)
Table Middle East Eculizumab Revenue Market Share by Countries (2012-2017)
Figure Middle East Eculizumab Revenue Market Share by Countries (2012-2017)
Figure Middle East Eculizumab Revenue Market Share by Countries in 2016
Figure Saudi Arabia Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Israel Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure UAE Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Iran Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Africa Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Africa Eculizumab Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Eculizumab Sales (K Vial) by Type (2012-2017)
Table Africa Eculizumab Sales Market Share by Type (2012-2017)
Figure Africa Eculizumab Sales Market Share by Type (2012-2017)
Figure Africa Eculizumab Sales Market Share by Type in 2016
Table Africa Eculizumab Sales (K Vial) by Application (2012-2017)
Table Africa Eculizumab Sales Market Share by Application (2012-2017)
Figure Africa Eculizumab Sales Market Share by Application (2012-2017)
Table Africa Eculizumab Sales Volume (K Vial) by Countries (2012-2017)
Table Africa Eculizumab Sales Market Share by Countries (2012-2017)
Figure Africa Eculizumab Sales Market Share by Countries (2012-2017)
Figure Africa Eculizumab Sales Market Share by Countries in 2016
Table Africa Eculizumab Revenue (Million USD) by Countries (2012-2017)
Table Africa Eculizumab Revenue Market Share by Countries (2012-2017)
Figure Africa Eculizumab Revenue Market Share by Countries (2012-2017)
Figure Africa Eculizumab Revenue Market Share by Countries in 2016
Figure South Africa Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Nigeria Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Egypt Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Algeria Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Table Alexion Eculizumab Basic Information List
Table Alexion Eculizumab Sales (K Vial), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alexion Eculizumab Sales (K Vial) and Growth Rate (2012-2017)
Figure Alexion Eculizumab Sales Market Share in EMEA (2012-2017)
Figure Alexion Eculizumab Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Eculizumab
Figure Manufacturing Process Analysis of Eculizumab
Figure Eculizumab Industrial Chain Analysis
Table Raw Materials Sources of Eculizumab Major Manufacturers in 2016
Table Major Buyers of Eculizumab
Table Distributors/Traders List
Figure EMEA Eculizumab Sales (K Vial) and Growth Rate Forecast (2017-2022)
Figure EMEA Eculizumab Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Eculizumab Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Eculizumab Sales (K Vial) Forecast by Region (2017-2022)
Figure EMEA Eculizumab Sales Market Share Forecast by Region (2017-2022)
Table EMEA Eculizumab Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Eculizumab Revenue Market Share Forecast by Region (2017-2022)
Table Europe Eculizumab Sales (K Vial) Forecast by Countries (2017-2022)
Figure Europe Eculizumab Sales Market Share Forecast by Countries (2017-2022)
Table Europe Eculizumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Eculizumab Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Eculizumab Sales (K Vial) Forecast by Countries (2017-2022)
Figure Middle East Eculizumab Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Eculizumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Eculizumab Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Eculizumab Sales (K Vial) Forecast by Countries (2017-2022)
Figure Africa Eculizumab Sales Market Share Forecast by Countries (2017-2022)
Table Africa Eculizumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Eculizumab Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Eculizumab Sales (K Vial) Forecast by Type (2017-2022)
Figure EMEA Eculizumab Sales Market Share Forecast by Type (2017-2022)
Table EMEA Eculizumab Sales (K Vial) Forecast by Application (2017-2022)
Figure EMEA Eculizumab Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources